All lobbying filings
SIDLEY AUSTIN LLP
SIDLEY AUSTIN LLP filed a Q3 termination report for INTERCEPT PHARMACEUTICALS, INC. on October 19, 2026, reporting no lobbying activity.
Lobbying for INTERCEPT PHARMACEUTICALS, INC. · Pharmaceutical manufacturer
Filing · LD-2 quarterly report
Q3 terminationNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey
Representation ended
Sep 30, 2026
The registrant reported terminating its work for this client.
Lobbying activity
0
No itemized activity in this filing.